The PD-1/PD-L1 pathway and its modulation are being widely studied in oncology, and the evolution of immunotherapy with antibodies against coinhibitory molecules in the treatment of cancer is one of the most successful therapeutic discoveries in recent years (16–18). This evidence concerns the gene PDCD1 and cancer.